期刊文献+

术前服用非那雄胺对减少钬激光前列腺剜除术中出血作用 被引量:6

Effect of finasteride on reducing hemorrhage in holmium lasterenucleation of prostate
原文传递
导出
摘要 目的评价经尿道钬激光前列腺剜除术(HoLEP)治疗良性前列腺增生(BPH)术前口服非那雄胺对减少术中出血量的影响。方法回顾性分析我院泌尿外科2010年9月至2012年3月156例BPH患者,其中术前口服非那雄胺5mg/d的79例为实验组,术前未服用非那雄胺77例患者为对照组,比较两组患者行HoLEP的手术时间、术中冲洗液、术前及术后血红蛋白含量的变化及术后冲洗时间。结果实验组术中冲洗液量(27.5±3.7)L、术前术后血红蛋白差值(1.1±0.3)g/L及术后冲洗时间(24.9±4.2)h与对照组术中冲洗液量(36.9±6.5)I。术前术后血红蛋白差值(1.6±0.3)g/L及术后冲洗时间(35.9±5.1)h比较均显著降低,差异均有统计学意义(均P〈O.05)。结论术前口服非那雄胺能显著减少HoLEP术的术中出血量,减少术后冲洗液用量。 Objective To evaluate the effect of preoperative oral finasteride on patients with benign prostate hyperplasia (BPH) undergoing holmium [asterenucleation of prostate (HoLEP). Methods A total of 156 BPH patients from Department of Urology in Shanghai Ninth People's Hospital from Sep. 2010 to Mar. 2012 was analyzed retrospectively. 79 patients receiving oral 5 mg/d finasteride before operation were selected as medication group, and the 77 patients without taking finasteride were selected as control group. The perioperative data, including operation time, amount of washing fluid during operation, preoperative and postoperative changes of hemoglobin level and postoperative bladder washing time were compared between two groups. Results Compared with control group, the changes of hemoglobin level after HoLEP, amount of washing fluid during operation, and postoperative bladder washing time with normal saline were significantly decreased in experimental group[(1.08±0.27) g/L vs. (1.55±0.32) g/L, (27.51±3.67) L vs. (36.89±6.47) L, (24.85±4.17) h vs. (35.87-+5.10) h, all P〈0.05]. Conclusions Oral finasteride before HoLEP can reduce perioperative bleedin~ and the volume of bladder irrigation with normal saline.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2014年第3期264-266,共3页 Chinese Journal of Geriatrics
基金 国家自然科学基金项目(81070544、81172450)
关键词 前列腺增生 出血 经尿道前列腺切除术 Prostatic hyperplasia Hemorrhage Transurethral resection of prostate
  • 相关文献

参考文献9

  • 1朱育春,钟玲,魏强.非那雄胺治疗经尿道前列腺切除术中出血的Meta分析[J].中国循证医学杂志,2008,8(6):456-460. 被引量:7
  • 2余小祥,周大庆,莫曾南,李文刚,王坚,刘尚文,禹长杰,张瑞明,邓程慧,何猛,杨洁秋.非那雄胺在经尿道前列腺双极等离子剜除术围手术期的临床应用[J].中华老年医学杂志,2011,30(11):930-933. 被引量:11
  • 3Gilling PJ. Laser enucleation is increasingly becoming the standard of care for treatment of benign prostatic hyperplasia of all sizes[J]. Eur Urol , 2013, 63: 868-869.
  • 4Letai A. Puma strikes Bax[J]. J Cell Biol, 2009, 185: 189-191.
  • 5Mavuduru RM, MandaI AK, Singh SK, et al. Comparison of HoLEP and TURP in terms of efficacy in the early postoperative period and perioperative morbidity[J]. Urol Int , 2009,82: 130-135.
  • 6Lourenco T, Armstrong N, N' Dow J, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement [J] . Health Technol Assess, 2008, 12: 1-146, 169-515.
  • 7Sinicrope FA, Rego RL, Okumura K, et al. Prognostic impact of bim , puma, and noxa expression in human colon carcinomas [J]. Clin Cancer Res, 2008, 14: 5810-5818.
  • 8Canda AE, Mungan MU, Yilmaz 0, et al. Effects of finasteride on the vascular surface density, number of microvessels and vascular endothelial growth factor expression of the rat prostate[J]. Int Urol Nephrol , 2006,38: 275-280.
  • 9刘孝东,杨宇如,卢一平,张秀辉,李凤媛,魏强,李虹,石明,陈宗福.非那雄胺减少TURP术中出血的机理研究[J].中华泌尿外科杂志,2003,24(10):694-696. 被引量:137

二级参考文献51

  • 1李涛,张延榕,刘春,何延瑜,陈梓甫.术前不同疗程非那雄胺对中重度前列腺增生手术出血的疗效观察[J].临床泌尿外科杂志,2005,20(8):469-471. 被引量:13
  • 2王建业 邵鸿勋.TURP术中出血量的测定[J].中华泌尿外科杂志,1990,11:146-147.
  • 3Sherwood JB, McConnell JD, Vazquez DJ, et al. Heterogeneity of 5 alphareduetase gene expression in benign prostatic hyperplasia. J Urol, 2003, 169: 575-579.
  • 4Franck-Lissbrant I, Haggstrom S, Damber JE, et al. Testosterone stimulates angiogenesis and vascularregrowth in the ventral prostate in castrated adult rats. Endocrinology, 1998, 139:451 456.
  • 5Haggstrom S, Wikstrom P, Bergh A, et al. Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration. Prostate, 1998, 36..71 79.
  • 6Sordello S,Bertrand N, Plouet J. Vascular endothelial growth factor is up regulated in vitro and in vivo by androgen. Biochem Biophy Res Commun, 1998, 251 ..287-290.
  • 7Foley SJ, Soloman LZ, Wedderburn AW , et al. A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Uro[,2000, 163:496-498.
  • 8Pareek G, Shevchuk M , Armenakas NA, et al. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol,2003, 169:20-23.
  • 9Haggstrom S,Torring N, Moller K,et al. Effects of finasteride on vascular endothelial growth factor. Scand J Urol Nephrol,2002, 36..182 187.
  • 10Bailey DM, Foley SJ, Wedderburn AW. Effect of Finasteride on microvessel density (MVD) in patients with recurrent hematuria related to prostatic hypertrophy. J Urol,1999,161:363.

共引文献151

同被引文献29

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部